New SEC Form D filing

Zai Lab Ltd, 2026-11-09

A new SEC Form D private-offering notice from Cambridge, MA, a $249,933,600 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Zai Lab Ltd site↗ Verified via SEC Form D

Commercial stage biopharmaceutical company developing and marketing therapies in oncology, immunology, neuroscience and infectious disease, publicly traded on Nasdaq as ZLAB

Filed 2026-11-09Filed to raise $249,933,600First money in 2026-10-27Raised so far $249,933,600HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) LateCall status Call-ready
Source linked the Form D on EDGAR↗Website verified zailaboratory.com↗Named in the filing 12 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source